Home

may18-hero

Achieving a Harmonized Guideline for Bioanalytical Method Validation: ICH M10

Career Success

may18-career-success

Crucial Conversations: A Look Inward

According to the book Crucial Conversations, there are two keys to creating safety in the course of a conversation: Mutual Purpose and Mutual Respect.

Read More

Special Feature

May18-sp-feature

Women in Pharmaceutical Sciences: How to Break the Glass Ceiling?

In this Special Feature, women share their challenges in the work place.


Read More

Pharmaceutical Science Update

Posted By Linda Brown
Found In Microsite: AAPS News Magazine
May 16, 2018 Research institutions now have additional clues on the path forward for modernizing regulations to protect research volunteers, even though it is not clear when they will take effect, research attorneys told Bloomberg Law. The regulatory ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
May 16, 2018 China’s new tax breaks for some imported and domestic drugs are the beginning of a broader series of cuts for pharmaceuticals. The government announced that as of May 1 it cut value-added tax (VAT) for all domestically produced cancer-fighting ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
May 16, 2018 A pair of Food and Drug Administration (FDA)-instigated lawsuits filed in Florida and California that seek to stop stem cell clinic operators from marketing unapproved treatments may make a bigger splash than it first seemed. Scott Gottlieb, ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
May 9, 2018 In the next few weeks, the Food and Drug Administration (FDA) will unveil a program to streamline approvals for complex drugs—commonly referred to as biosimilars—in an attempt to stem skyrocketing drug prices and improve drug accessibility ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
May 9, 2018 On April 30, the University of California (UC) at Berkeley pressed its case to reverse a patent board decision in a high-stakes fight over intellectual property rights to the revolutionary gene-editing technology CRISPR-Cas9. A U.S. Patent ...